Sherrington Robin Xenon Pharmaceuticals Inc. (XENE) insider trading activity
Sherrington Robin is EVP, Strategy & Innovation of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 8,398 shares of XENE, which is worth approximately $324,414. The most recent transaction as insider was on Mar 07, 2024, when has been sold 7,137 shares (Common Shares) at a price of $46.23 per share, resulting in proceeds of $329,943. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
8.4K
0%
3M change
50.0%
12M change
Total Value Held
$324,414
SHERRINGTON ROBIN Transaction History
SR
Sherrington Robin
EVP, Strategy & Innovation
Burnaby, A1